Clinical and pet effects of M100907, a selective 5HT-2A receptor antagonist

被引：0
|
作者：
Potkin, SG
Shipley, J
Bera, RB
Carreon, D
Fallon, J
Alva, G
Keator, D
机构：
[1] Univ Calif Irvine, Irvine, CA 92697 USA
[2] Univ Calif Irvine, Aventis Pharmaceut, Brain Imaging Ctr, Irvine, CA 92697 USA
来源：
SCHIZOPHRENIA RESEARCH | 2001年 / 49卷 / 1-2期
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：242 / 242
页数：1
相关论文
共 50 条
  • [1] The 5-HT2A receptor antagonist M100907 produces antiparkinsonian effects and decreases striatal glutamate
    Ansah, Twum A.
    Ferguson, Marcus C.
    Nayyar, Tultul
    FRONTIERS IN SYSTEMS NEUROSCIENCE, 2011, 5
  • [2] The selective 5-HT2A receptor antagonist M100907 enhances antidepressant-like behavioral effects of the SSRI fluoxetine
    Marek, GJ
    Martin-Ruiz, R
    Abo, A
    Artigas, F
    NEUROPSYCHOPHARMACOLOGY, 2005, 30 (12) : 2205 - 2215
  • [3] The Selective 5-HT2A Receptor Antagonist M100907 Enhances Antidepressant-Like Behavioral Effects of the SSRI Fluoxetine
    Gerard J Marek
    Raul Martin-Ruiz
    Allyson Abo
    Francesc Artigas
    Neuropsychopharmacology, 2005, 30 : 2205 - 2215
  • [4] 5-HT2A receptor antagonist M100907 reduces serotonin synthesis: An autoradiographic study
    Hasegawa, Shu
    Fikre-Merid, Maraki
    Diksic, Mirko
    BRAIN RESEARCH BULLETIN, 2012, 87 (01) : 44 - 49
  • [5] Synthesis and activity of functionalizable derivatives of the serotonin (5-HT) 5-HT2A receptor (5-HT2AR) antagonist M100907
    Gilbertson, Scott R.
    Chen, Ying-Chu
    Soto, Claudia A.
    Yang, Yaxing
    Rice, Kenner C.
    Cunningham, Kathryn A.
    Anastasio, Noelle C.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2018, 28 (08) : 1381 - 1385
  • [6] Actions of the 5-HT2A antagonist M100907 in serotonin-depleted mice
    Fantegrossi, WE
    Kilbourn, M
    Woods, JH
    FASEB JOURNAL, 2004, 18 (05): : A965 - A965
  • [7] M100907, a selective 5-HT2A receptor antagonist, attenuates phencyclidine-induced Fos expression in discrete regions of rat brain
    Habara, T
    Hamamura, M
    Miki, M
    Ohashi, K
    Fujiwara, Y
    Kuroda, S
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2002, 17 : S122 - S122
  • [8] M100907, a selective 5-HT2A receptor antagonist, attenuates phencyclidine-induced Fos expression in discrete regions of rat brain
    Habara, T
    Hamamura, T
    Miki, M
    Ohashi, K
    Kuroda, S
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 417 (03) : 189 - 194
  • [9] The apparent antipsychotic action of the 5-HT2a receptor antagonist M100907 in a mouse model of schizophrenia is counteracted by ritanserin
    P. Martin
    N. Waters
    A. Carlsson
    M. L. Carlsson
    Journal of Neural Transmission, 1997, 104 : 561 - 564
  • [10] A high central 5HT2A a receptor occupancy in M100907-treated schizophrenic patients demonstrated with pet and [11C]M100907
    Talvik-Lotfi, M
    Nyberg, S
    Nordström, AL
    Ito, H
    Halldin, C
    Brunner, F
    Farde, L
    SCHIZOPHRENIA RESEARCH, 1999, 36 (1-3) : 109 - 110
12345